Literature DB >> 13977209

The psychedelic experience--a new concept in psychotherapy.

J N SHERWOOD, M J STOLAROFF, W W HARMAN.   

Abstract

Keywords:  LYSERGIC ACID DIETHYLAMIDE; MESCALINE; PSYCHOTHERAPY

Mesh：

Substances：

Year:  1962        PMID： 13977209

Source DB:  PubMed          Journal:  J Neuropsychiatr


× No keyword cloud information.
  7 in total

1.  Implications of LSD and experimental mysticism.

Authors:  W N Pahnke; W A Richards
Journal:  J Relig Health       Date:  1966-07

Review 2.  Lysergic acid diethylamide: a drug of 'use'?

Authors:  Saibal Das; Preeti Barnwal; Anand Ramasamy; Sumalya Sen; Somnath Mondal
Journal:  Ther Adv Psychopharmacol       Date:  2016-03-23

3.  Clinical prediction of insightful response to a single large dose of LSD.

Authors:  D C Eggert; C Shagass
Journal:  Psychopharmacologia       Date:  1966

4.  Foundations for Training Psychedelic Therapists.

Authors:  Janis Phelps; James Henry
Journal:  Curr Top Behav Neurosci       Date:  2022

5.  Clinical Interpretations of Patient Experience in a Trial of Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder.

Authors:  Michael P Bogenschutz; Samantha K Podrebarac; Jessie H Duane; Sean S Amegadzie; Tara C Malone; Lindsey T Owens; Stephen Ross; Sarah E Mennenga
Journal:  Front Pharmacol       Date:  2018-02-20       Impact factor: 5.810

6.  Individual Experiences in Four Cancer Patients Following Psilocybin-Assisted Psychotherapy.

Authors:  Tara C Malone; Sarah E Mennenga; Jeffrey Guss; Samantha K Podrebarac; Lindsey T Owens; Anthony P Bossis; Alexander B Belser; Gabrielle Agin-Liebes; Michael P Bogenschutz; Stephen Ross
Journal:  Front Pharmacol       Date:  2018-04-03       Impact factor: 5.810

7.  Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression.

Authors:  Leor Roseman; David J Nutt; Robin L Carhart-Harris
Journal:  Front Pharmacol       Date:  2018-01-17       Impact factor: 5.810
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.